10-of-my-most-popular-text-to-image-series-prompts-78b0897e
generate a bunch of images, then you curate the results to handpick the best ones
ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) prediction for drug candidates. Use for assessing drug-likeness, PK properties, and safety risks early in drug discovery. Keywords: ADMET, PK, toxicity, drug-likeness, DILI, hERG, bioavailability
Follow the repository instructions for this skill and your agent. Review the files and dependencies before adding it to your workflow.
SkillHub CLI
skillhub install huifer/admet-predictionInspect the source and compatibility requirements, then follow its installation steps.
Give your agent the source link and ask it to inspect instructions and dependencies before explaining the installation steps.
Predict ADMET properties to prioritize compounds for development.
/admet "CC1=CC=C(C=C1)CNC" --full
/pk-prediction --library compounds.sdf --threshold 0.7
/toxicity-screen CHEMBL210 --include hERG,DILI,Ames
| Property | Prediction | Model |
|---|---|---|
| Absorption | Caco-2, HIA, Pgp | ML/QSAR |
| Distribution | VDss, PPB, BBB | ML/QSAR |
| Metabolism | CYP inhibition, clearance | ML/QSAR |
| Excretion | Clearance, half-life | ML/QSAR |
| Toxicity | hERG, DILI, Ames, mutagenicity | ML/QSAR |
# ADMET Profile: CHEMBL210 (Osimertinib)
## Summary
| Property | Value | Status |
|----------|-------|--------|
| Drug-likeness | Pass | ✓ |
| Lipinski Ro5 | 0 violations | ✓ |
| VEBER | Pass | ✓ |
| PAINS | 0 alerts | ✓ |
| Brenk | 0 alerts | ✓ |
## Absorption
| Property | Prediction | Confidence |
|----------|------------|-------------|
| HIA | 98% | High |
| Caco-2 | 15.2 × 10⁻⁶ cm/s | High |
| Pgp substrate | Yes | Medium |
| F30% | 65% | Medium |
## Distribution
| Property | Prediction | Confidence |
|----------|------------|-------------|
| VDss | 5.2 L/kg | Medium |
| PPB | 95% | High |
| BBB | Yes | High |
| CNS MPO | 5.5 | Good |
## Metabolism
| Property | Prediction | Confidence |
|----------|------------|-------------|
| CYP3A4 substrate | Yes | High |
| CYP3A4 inhibitor | Yes | Medium |
| CYP2D6 inhibitor | No | High |
| CYP2C9 inhibitor | No | Medium |
| Clearance | 8.5 mL/min/kg | Low |
## Excretion
| Property | Prediction | Confidence |
|----------|------------|-------------|
| Renal clearance | 10% | Medium |
| Half-life | 48 hours | High |
## Toxicity
| Property | Prediction | Confidence |
|----------|------------|-------------|
| hERG inhibition | No | High |
| DILI | Concern | Medium |
| Ames mutagenicity | Negative | High |
| Carcinogenicity | Negative | Medium |
| Respiratory toxicity | No | Low |
## Recommendations
**Strengt...
These signals come from indexed source analysis and may lag behind changes. Check the current source files.
# ADMET Prediction Skill Predict ADMET properties to prioritize compounds for development. ## Quick Start ``` /admet "CC1=CC=C(C=C1)CNC" --full /pk-prediction --library compounds.sdf --threshold 0.7 /toxicity-screen CHEMBL210 --include hERG,DILI,Ames ``` ## What's Included | Property | Prediction | Model | |----------|------------|-------| | Absorption | Caco-2, HIA, Pgp | ML/QSAR | | Distribution | VDss, PPB, BBB | ML/QSAR | | Metabolism | CYP inhibition, clearance | ML/QSAR | | Excretion | Clearance, half-life | ML/QSAR | | Toxicity | hERG, DILI, Ames, mutagenicity | ML/QSAR | ## Output Structure ```markdown # ADMET Profile: CHEMBL210 (Osimertinib) ## Summary | Property | Value | Status | |----------|-------|--------| | Drug-likeness | Pass | ✓ | | Lipinski Ro5 | 0 violations | ✓ | | VEBER | Pass | ✓ | | PAINS | 0 alerts | ✓ | | Brenk | 0 alerts | ✓ | ## Absorption | Property | Prediction | Confidence | |----------|------------|-------------| | HIA | 98% | High | | Caco-2 | 15.2 × 10⁻⁶ cm/s | High | | Pgp substrate | Yes | Medium | | F30% | 65% | Medium | ## Distribution | Property | Prediction | Confidence | |----------|------------|-------------| | VDss | 5.2 L/kg | Medium | | PPB | 95% | High | | BBB | Yes | High | | CNS MPO | 5.5 | Good | ## Metabolism | Property | Prediction | Confidence | |----------|------------|-------------| | CYP3A4 substrate | Yes | High | | CYP3A4 inhibitor | Yes | Medium | | CYP2D6 inhibitor | No | High | | CYP2C9 inhibitor | No | Medium | | Clearance | 8.5 mL/min/kg | Low | ## Excretion | Property | Prediction | Confidence | |----------|------------|-------------| | Renal clearance | 10% | Medium | | Half-life | 48 hours | High | ## Toxicity | Property | Prediction | Confidence | |----------|------------|-------------| | hERG inhibition | No | High | | DILI | Concern | Medium | | Ames mutagenicity | Negative | High | | Carcinogenicity | Negative | Medium | | Respiratory toxicity | No | Low | ## Recommendations **Strengt...
generate a bunch of images, then you curate the results to handpick the best ones
generate a bunch of images, then you curate the results to handpick the best ones
Productivity system based on Maya calendar with 13 natural tones for project management and personal development
Set up and use 1Password CLI (op). Use when installing the CLI, enabling desktop app integration, signing in (single or multi-account), or reading/injecting/running secrets via op.